Indranil Dey is President and CEO of Bluejay Diagnostics, Inc.. Currently has a direct ownership of 28,526 shares of BJDX, which is worth approximately $4,278. The most recent transaction as insider was on Dec 13, 2023, when has been sold 500 shares (Common Stock) at a price of $3.27 per share, resulting in proceeds of $1,635. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.5K
0% 3M change
95.68% 12M change
Total Value Held $4,278

Indranil Dey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2023
BUY
Open market or private purchase
$1,635 $3.27 p/Share
500 Added 1.72%
28,526 Common Stock
Mar 28 2023
BUY
Grant, award, or other acquisition
$880 $0.44 p/Share
2,000 Added 0.3%
660,538 Common Stock
Mar 27 2023
BUY
Grant, award, or other acquisition
$3,520 $0.44 p/Share
8,000 Added 1.41%
558,538 Common Stock
Feb 01 2023
SELL
Payment of exercise price or tax liability
$24,469 $0.44 p/Share
55,612 Reduced 9.17%
550,538 Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
$69,999 $0.44 p/Share
159,090 Added 20.79%
606,150 Common Stock
ID

Indranil Dey

President and CEO
Acton, MA

Track Institutional and Insider Activities on BJDX

Follow Bluejay Diagnostics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BJDX shares.

Notify only if

Insider Trading

Get notified when an Bluejay Diagnostics, Inc. insider buys or sells BJDX shares.

Notify only if

News

Receive news related to Bluejay Diagnostics, Inc.

Track Activities on BJDX